Oncodiag Overview

  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $682K
Latest Deal Amount
  • Investors
  • 4

Oncodiag General Information


Manufacturer of diagnostic devices designed for urological cancers. The company's products specialize in the development of innovative solutions for the early diagnosis and monitoring of cancers especially bladder and colorectal cancer, enabling doctors to diagnose and monitor patients with cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 9 Rue de Pacy
  • 27930 Miserey
  • France
+33 02 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncodiag Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 14-Dec-2018 $682K 00000 Completed Generating Revenue
1. Accelerator/Incubator 05-Jun-2014 Completed Generating Revenue
To view Oncodiag’s complete valuation and funding history, request access »

Oncodiag Executive Team (2)

Name Title Board Seat Contact Info
Claude Hennion Ph.D Co-Founder, President & Chief Executive Officer
Jean-Pierre Roperch Ph.D Co-Founder & Director, Research & Development
To view Oncodiag’s complete executive team members history, request access »

Oncodiag Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angels Santé Angel Group Minority 000 0000 000000 0
Les Business Angels des Grandes Écoles Angel Group Minority 000 0000 000000 0
Normandie Business Angels Angel Group Minority 000 0000 000000 0
Agoranov Accelerator/Incubator Minority 000 0000 000000 0
To view Oncodiag’s complete investors history, request access »